483
BioSurg, Inc.FDA 483 - BioSurg, Inc. - April 19, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of BioSurg, Inc., a nonclinical laboratory in Winters, CA, from April 15-19, 2019, revealed several significant deficiencies. Findings included non-adherence to study protocols, failure to properly archive study specimens, and inadequate retention of reserve samples. Additionally, the firm failed to authorize and document deviations from standard operating procedures, specifically regarding out-of-range refrigerator temperatures for test articles.
Open in Dashboard
ID · ab64a560-3480-42a7-847f-9f74199d033e